Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers

被引:264
作者
Finch, A
Shaw, P
Rosen, B
Murphy, J
Narod, SA
Colgan, TJ
机构
[1] Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada
[2] Mt Sinai Hosp, Dept Lab Med & Pathobiol, Toronto, ON, Canada
关键词
salpingo-oophorectomy; BRCA1; BRCA2;
D O I
10.1016/j.ygyno.2005.06.065
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To estimate the likelihood of Occult cancer diagnosis at prophylactic oophorectomy in BRCA1 and BRCA2 carriers in different age groups and to determine the histopathology of these lesions. Methods. We describe a series of 159 female BRCA1 or BRCA2 carriers who underwent prophylactic oophorectomy at the University Health Network, Toronto from January 1, 1992 to June 30, 2004. Results. Seven (4.4%) occult cancers were detected at pathologic examination. None of the 159 subjects had clinical signs or symptoms of ovarian carcinoma prior to, or at the time of, surgery. Only two cancers were grossly visible at surgery. There were 94 BRCA1 carriers, of whom six were found to have an occult cancer (6.4%). In contrast, only one of the 65 BRCA2 carriers was found to have an occult cancer (1.5%). Three of the seven cases Of Occult Malignancy involved the fallopian tube and not the ovaries. Conclusion. Approximately 6% of BRCA1 Carriers and 2% of BRCA2 carriers who undergo prophylactic salpingo-oophorectomy will be found to have Occult carcinomas if the ovaries and tubes are rigorously examined. A significant proportion of these appear to originate in the fallopian tube. No cancers were detected among women who had the operation at age 39 or younger. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 23 条
  • [1] [Anonymous], 1995, JAMA, V273, P491
  • [2] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
    Antoniou, A
    Pharoah, PDP
    Narod, S
    Risch, HA
    Eyfjord, JE
    Hopper, JL
    Loman, N
    Olsson, H
    Johannsson, O
    Borg, Å
    Pasini, B
    Radice, P
    Manoukian, S
    Eccles, DM
    Tang, N
    Olah, E
    Anton-Culver, H
    Warner, E
    Lubinski, J
    Gronwald, J
    Gorski, B
    Tulinius, H
    Thorlacius, S
    Eerola, H
    Nevanlinna, H
    Syrjäkoski, K
    Kallioniemi, OP
    Thompson, D
    Evans, C
    Peto, J
    Lalloo, F
    Evans, DG
    Easton, DF
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) : 1117 - 1130
  • [3] A genetic epidemiological study of carcinoma of the fallopian tube
    Aziz, S
    Kuperstein, G
    Rosen, B
    Cole, D
    Nedelcu, R
    McLaughlin, J
    Narod, SA
    [J]. GYNECOLOGIC ONCOLOGY, 2001, 80 (03) : 341 - 345
  • [4] Peritoneal lavage cytology: An assessment of its value during prophylactic oophorectomy
    Colgan, TJ
    Boerner, SL
    Murphy, J
    Cole, DEC
    Narod, S
    Rosen, B
    [J]. GYNECOLOGIC ONCOLOGY, 2002, 85 (03) : 397 - 403
  • [5] Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status
    Colgan, TJ
    Murphy, J
    Cole, DEC
    Narod, S
    Rosen, B
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (10) : 1283 - 1289
  • [6] The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: Does the emperor have no clothes?
    Dubeau, L
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 72 (03) : 437 - 442
  • [7] Eisen A, 2000, AM J HUM GENET, V67, P58
  • [8] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
    Ford, D
    Easton, DF
    Stratton, M
    Narod, S
    Goldgar, D
    Devilee, P
    Bishop, DT
    Weber, B
    Lenoir, G
    Chang-Claude, J
    Sobol, H
    Teare, MD
    Struewing, J
    Arason, A
    Scherneck, S
    Peto, J
    Rebbeck, TR
    Tonin, P
    Neuhausen, S
    Barkardottir, R
    Eyfjord, J
    Lynch, H
    Ponder, BAJ
    Gayther, SA
    Birch, JM
    Lindblom, A
    Stoppa-Lyonnet, D
    Bignon, Y
    Borg, A
    Hamann, U
    Haites, N
    Scott, RJ
    Maugard, CM
    Vasen, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) : 676 - 689
  • [9] Of mice and women
    Foulkes, WD
    [J]. CANCER CELL, 2002, 1 (01) : 11 - 12
  • [10] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff, ND
    Satagopan, JM
    Robson, ME
    Scheuer, L
    Hensley, M
    Hudis, CA
    Ellis, NA
    Boyd, J
    Borgen, PI
    Barakat, RR
    Norton, L
    Offit, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) : 1609 - 1615